Frontlight ResearchEarly access
CompletedNo phase
Ablation in Brugada Syndrome for the Prevention of VF
Key facts
- Who runs it
- Pacific Rim Electrophysiology Research Institute
- Where
- Netherlands and Thailand6 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 200 people enrolled
- Started
- Jul 2016
- Ended
- 13 Nov 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Catheter Ablation
- Record updated
- 21 November 2024
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- The diagnosis of Brugada syndrome is based on 2013 HRS/EHRA/APHRS Consensus document criteria
- Diagnosed symptomatic BrS with an implanted ICD within the last 5 years
- Diagnosed symptomatic BrS with an implanted ICD longer than 5 years but has at least 1 appropriate shock within the last 5 years
- The patient is legally competent, willing and able to undergo the study and signed the informed consent
- The patient is willing and able to adhere to the follow-up visit protocol
Who cannot take part
- A patient who has had a previous epicardial ablation
- A patient with a co-morbid condition that possesses undue risk of general anesthesia or epicardial ablation
- A patient who has a history of radiation therapy on the thorax
- A patient who does not meet inclusion criteria
- A patient who is pregnant (which would exclude an ablation procedure)
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
This trial aims to develop evidence based curative treatment with optimal net benefit for patients with Brugada syndrome.
The 3 groups in the trial
- Control armNo study treatment, for comparison
Control arm - continued implanted cardioverter defibrillator therapy
- Intervention ArmExisting treatment, for comparison
ablation of areas of fragmented signal in the right ventricular outflow tract plus continued implanted cardioverter defibrillator therapy
Treatment: Catheter Ablation
- Single Cross Over ArmOther group
these patients were initially assigned to the control arm of the study. When these patients met the primary outcome of the study it is allowed for these patients to be included in the intervention arm and/or to start quinidine
Treatment: Catheter Ablation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Ablation in Brugada Syndrome for Prevention of VF - A Randomized, Multi-center Study of Epicardial Ablation in Brugada Syndrome Patients to Prevent Arrhythmia Recurrence
- Record updated
- 21 November 2024